Overview

Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult Subjects

Status:
Completed
Trial end date:
2018-12-13
Target enrollment:
Participant gender:
Summary
A Non-Randomized, Open-Label, Two-Part, Drug-Drug Interaction Study to Evaluate the Effects of Cyclosporine and Prednisone on the Pharmacokinetics and Safety of EDP-938 in Healthy Adult Subjects
Phase:
Phase 1
Details
Lead Sponsor:
Enanta Pharmaceuticals
Collaborator:
Pharmaceutical Research Associates
Treatments:
Cyclosporine
Cyclosporins
Prednisone